Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 1, 2003, Pages 281-289

  Marchini, Giorgio ^a,b   Babighian, Silvia ^a   Tosi, Roberto ^a   Perfetti, Sergio ^a   Bonomi, Luciano ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b BORGO TRENTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; IBOPAMINE; PHENYLEPHRINE; TROPICAMIDE;

A SCAN; ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; BIOMICROSCOPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EYE REFRACTION; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MYDRIASIS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUPIL; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY;

ADULT; AGED; ANTERIOR EYE SEGMENT; DEOXYEPINEPHRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; IRIS; MALE; MIDDLE AGED; MYDRIATICS; OPHTHALMIC SOLUTIONS; PHENYLEPHRINE; PROSPECTIVE STUDIES; PUPIL; REFRACTION, OCULAR; TIME FACTORS; TROPICAMIDE; VISUAL ACUITY;

EID: 0037250464     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0221     Document Type: Article

References (15)

1. Itoh H. Clinical pharmacology of ibopamine. Am J Med. 1991;90:36S-42S.
2. Daul A, Elter-Schulz M, Poller U, et al. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers. Naunyn-Scbmiedebergs Arch Pharmacol. 1995;352:429-437.
3. Potter DE, Crosson CE, Heath AR, Ogidigben MJ. Alpha2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential (Review). J Ocul Pharmacol 1990;6:251-257.
4. Bonomi L, Bellucci R, Perfetti S, De Franco I, Albertini R. Effetto ipotensivo oculare di alcuni farmaci dopaminergici nel coniglio. Boll Ocul. 1992;71(suppl 2):219-229.
5. Virno M, Pecori Giraldi J, Taverniti L, De Gregorio F, Sedran L. L'ibopamina in Oftalmologia. Rome: Innovation News Communication; 1998.
6. Virno M, Pecori Giraldi J, Taverniti L, Taloni M, Pannarale MR. Intraocular hypertensive effects of topically administered ibopamine in eyes with hydrodynamic disorders: a new provocative test for glaucoma. Glaucoma. 1990;12:88-92.
7. Virno M, Taverniti L, De Gregorio F, Sedran L, Longo F. Increase in aqueous humor production following D1 receptor activation by means of ibopamine. Int Ophthalmol. 1996-1997;20:141-146.
8. Marchini G, Babighian S, Tosi R, Perfetti S, Bonomi L. Effects of 2% ibopamine on pupil, refraction, anterior segment anatomy and intraocular pressure. J Ocul Pharmacol. 2001;17:215-223.
9. Mapstone R. Safe mydriasis. Br J Ophthalmol. 1970;54:690-692.
10. Lo Presti L, Morgese A, Ravot M, Brogliatti B, Boles Carenini B. Ultrabiomicroscopic study of brimonidine, apraclonidine, latanoprost and ibopamine on the chamber angle and ciliary body. Acta Ophthalmol Scand. 1998;76(suppl):32-34.
11. Bonomi L, Bonora A. Proposta di una nuova metodica per la misurazione clinica del diametro pupillare. Boll Ocul. 1993;72:1163-1168.
12. Markowitz SN, Morin JD. The ratio of lens thickness to axial length for biometric standardization in angle-closure glaucoma. Am J Ophthalmol. 1985;99:400-402.
13. Lowe RF. Aetiology of the anatomical basis for primary angleclosure glaucoma. Br J Ophthalmol. 1970;54:161-169.
14. Marchini G, Pagliarusco A, Toscano A, Tosi R, Brunelli C, Bonomi L. Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle-closure glaucoma. Ophthalmology. 1998;105:2091-2098.
15. Pavlin CJ, Harasiewicz K, Foster FS. Ultrasound biomicroscopy of anterior segment structures in normal and glaucomatous eyes. Am J Ophthalmol. 1992;113:381-389.